欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0210/005
药品名称
Reminyl
活性成分
galantamine 8.0 mg
剂型
Prolonged-release capsule, hard
上市许可持有人
Janssen-Cilag AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Belgium (BE)
Luxembourg (LU)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Reminyl 8 mg Retardkapseln
Portugal (PT)
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
Spain (ES)
许可日期
2004/09/28
最近更新日期
2024/07/16
药物ATC编码
N06DA04 galantamine
申请类型
TypeLevel1:
Line Extension
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0210_005_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0210_005_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase